Danny Hart
2014
In 2014, Danny Hart earned a total compensation of $1.4M as Vice President, Business Development at PDL BioPharma, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $776,550 |
|---|---|
| Salary | $343,075 |
| Stock Awards | $217,500 |
| Other | $40,000 |
| Total | $1,377,125 |
Hart received $776.6K in non-equity incentive plan, accounting for 56% of the total pay in 2014.
Hart also received $343.1K in salary, $217.5K in stock awards and $40K in other compensation.
Rankings
In 2014, Danny Hart's compensation ranked 6,166th out of 13,032 executives tracked by ExecPay. In other words, Hart earned more than 52.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,166 out of 13,032 | 53rd |
Division Manufacturing | 2,242 out of 4,965 | 55th |
Major group Chemicals And Allied Products | 747 out of 1,690 | 56th |
Industry group Drugs | 584 out of 1,369 | 57th |
Industry Biological Products, Except Diagnostic Substances | 111 out of 241 | 54th |
Source: SEC filing on April 28, 2017.
Hart's colleagues
We found four more compensation records of executives who worked with Danny Hart at PDL BioPharma in 2014.